Federal Register / Vol. 88, No. 164 / Friday, August 25, 2023 / Notices 58277 

DEPARTMENT OF DEFENSE 

GENERAL SERVICES 

ADMINISTRATION 

NATIONAL AERONAUTICS AND 

SPACE ADMINISTRATION 

[OMB Control No. 9000–0011; Docket No. 

2023–0053; Sequence No. 4] 

Submission for OMB Review; 

Preaward Survey Forms (Standard 

Forms 1403, 1404, 1405, 1406, 1407, 

and 1408) 

AGENCY: Department of Defense (DOD), 

General Services Administration (GSA), 

and National Aeronautics and Space 

Administration (NASA). 

ACTION: Notice. 

SUMMARY: Under the provisions of the 

Paperwork Reduction Act, the 

Regulatory Secretariat Division has 

submitted to the Office of Management 

and Budget (OMB) a request to review 

and approve an extension of a 

previously approved information 

collection requirement regarding 

preaward survey forms. 

DATES: Submit comments on or before 

September 25, 2023. 

ADDRESSES: Written comments and 

recommendations for this information 

collection should be sent within 30 days 

of publication of this notice to 

www.reginfo.gov/public/do/PRAMain. 

Find this particular information 

collection by selecting ‘‘Currently under 

Review—Open for Public Comments’’ or 

by using the search function. 

Additionally, submit a copy to GSA 

through https://www.regulations.gov 

and follow the instructions on the site. 

This website provides the ability to type 

short comments directly into the 

comment field or attach a file for 

lengthier comments. 

Instructions: All items submitted 

must cite OMB Control No. 9000–0011, 

Preaward Survey Forms (Standard 

Forms 1403, 1404, 1405, 1406, 1407, 

and 1408). Comments received generally 

will be posted without change to 

https://www.regulations.gov, including 

any personal and/or business 

confidential information provided. To 

confirm receipt of your comment(s), 

please check www.regulations.gov, 

approximately two-to-three days after 

submission to verify posting. If there are 

difficulties submitting comments, 

contact the GSA Regulatory Secretariat 

Division at 202–501–4755 or 

GSARegSec@gsa.gov. 

FOR FURTHER INFORMATION CONTACT: 

Zenaida Delgado, Procurement Analyst, 

at telephone 202–969–7207, or 

zenaida.delgado@gsa.gov. 

SUPPLEMENTARY INFORMATION: 

A. OMB Control Number, Title, and 

Any Associated Form(s) 

9000–0011, Preaward Survey Forms 

(Standard Forms 1403, 1404, 1405, 

1406, 1407, and 1408). 

B. Need and Uses 

Contracting officers, prior to award, 

must make an affirmative determination 

that the prospective contractor is 

responsible, i.e., capable of performing 

the contract. Before making such a 

determination, the contracting officer 

must have or obtain sufficient 

information to establish that the 

prospective contractor: has adequate 

financial resources; or the ability to 

obtain such resources; is able to comply 

with required delivery schedule; has a 

satisfactory record of performance; has a 

satisfactory record of integrity; and is 

otherwise qualified and eligible to 

receive an award under appropriate 

laws and regulations. If such 

information is not readily available to 

the contracting officer, it is obtained 

through a preaward survey conducted 

by the contract administration office or 

another organization designated by the 

agency to conduct the surveys. The 

necessary data is collected from 

available data or through plant visits, 

phone calls, and correspondence in 

detail commensurate with the dollar 

value and complexity of the 

procurement. This clearance covers the 

information that prospective contractors 

must provide to ensure proper 

completion of the following preaward 

survey forms prescribed by the Federal 

Acquisition Regulation (FAR): 

• Standard Form 1403 Preaward Survey 

of Prospective Contractor (General) 

• Standard Form 1404 Preaward Survey 

of Prospective Contractor (Technical) 

• Standard Form 1405 Preaward Survey 

of Prospective Contractor (Production) 

• Standard Form 1406 Preaward Survey 

of Prospective Contractor (Quality 

Assurance) 

• Standard Form 1407 Preaward Survey 

of Prospective Contractor (Financial 

Capability) 

• Standard Form 1408 Preaward Survey 

of Prospective Contractor (Accounting 

System) 

C. Common Form 

The General Services Administration 

is the sponsor agency of this common 

form. All executive agencies covered by 

the FAR will use this common form. 

Each executive agency will report their 

agency burden separately, and the 

reported information will be available at 

Reginfo.gov. 

D. Annual Burden 

General Services Administration 

Respondents: 168. 

Total Annual Responses: 168. 

Total Burden Hours: 4,032. 

E. Public Comment 

A 60-day notice was published in the 

Federal Register at 88 FR 39849, on 

June 20, 2023. No comments were 

received. 

Obtaining Copies: Requesters may 

obtain a copy of the information 

collection documents from the GSA 

Regulatory Secretariat Division by 

calling 202–501–4755 or emailing 

GSARegSec@gsa.gov. Please cite OMB 

Control No. 9000–0011, Preaward 

Survey Forms (Standard Forms 1403, 

1404, 1405, 1406, 1407, and 1408). 

Janet Fry, 

Director, Federal Acquisition Policy Division, 

Office of Governmentwide Acquisition Policy, 

Office of Acquisition Policy, Office of 

Governmentwide Policy. 

[FR Doc. 2023–18352 Filed 8–24–23; 8:45 am] 

BILLING CODE 6820–EP–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

[Docket No. CDC–2023–0060] 

Advisory Committee on Immunization 

Practices 

AGENCY: Centers for Disease Control and 

Prevention (CDC), Department of Health 

and Human Services (HHS). 

ACTION: Notice and request for comment. 

SUMMARY: In accordance with regulatory 

provisions, the Centers for Disease 

Control and Prevention (CDC) 

announces the following meeting of the 

Advisory Committee on Immunization 

Practices (ACIP). This meeting is open 

to the public. Time will be available for 

public comment. 

DATES: The meeting will be held on 

September 12, 2023, 10 a.m. to 4 p.m., 

EDT (date and times subject to change; 

see the ACIP website for updates: 

https://www.cdc.gov/vaccines/acip/ 

index.htm). 

Written comments will be received 

between August 25–September 8, 2023. 

ADDRESSES: You may submit comments, 

identified by Docket No. CDC–2023– 

0060, by either of the methods listed 

below. CDC does not accept comments 

by email. 

• Federal eRulemaking Portal: 

https://www.regulations.gov. Follow the 

instructions for submitting comments. 


ddrumheller on DSK120RN23PROD with NOTICES1
58278 Federal Register / Vol. 88, No. 164 / Friday, August 25, 2023 / Notices 

• Mail: Ms. Stephanie Thomas, ACIP 

Meeting, Centers for Disease Control 

and Prevention, 1600 Clifton Road NE, 

Mailstop H24–8, Atlanta, Georgia 

30329–4027. Attn: Docket No. CDC– 

2023–0060. 

Instructions: All submissions received 

must include the Agency name and 

docket number. All relevant comments 

received in conformance with the 

https://www.regulations.gov suitability 

policy will be posted without change to 

https://www.regulations.gov, including 

any personal information provided. For 

access to the docket to read background 

documents or comments received, go to 

https://www.regulations.gov. 

The meeting will be webcast live via 

the World Wide Web. The webcast link 

can be found on the ACIP website at 

https://www.cdc.gov/vaccines/acip/ 

index.html. 

FOR FURTHER INFORMATION CONTACT: Ms. 

Stephanie Thomas, Committee 

Management Specialist, Advisory 

Committee on Immunization Practices, 

National Center for Immunization and 

Respiratory Diseases, Centers for 

Disease Control and Prevention, 1600 

Clifton Road NE, Mailstop H24–8, 

Atlanta, Georgia 30329–4027. 

Telephone: (404) 639–8836; Email: 

ACIP@cdc.gov. 

SUPPLEMENTARY INFORMATION: 

Purpose: The Advisory Committee on 

Immunization Practices (ACIP) is 

charged with advising the Director, 

Centers for Disease Control and 

Prevention (CDC), on the use of 

immunizing agents. In addition, under 

42 U.S.C. 1396s, the Committee is 

mandated to establish and periodically 

review and, as appropriate, revise the 

list of vaccines for administration to 

vaccine-eligible children through the 

Vaccines For Children program, along 

with schedules regarding dosing 

interval, dosage, and contraindications 

to administration of vaccines. Further, 

under applicable provisions of the 

Affordable Care Act and section 2713 of 

the Public Health Service Act, 

immunization recommendations of 

ACIP that have been approved by the 

Director, CDC, and appear on CDC 

immunization schedules generally must 

be covered by applicable health plans. 

Matters To Be Considered: The agenda 

will include discussion of COVID–19 

vaccines. Recommendation votes for 

COVID–19 vaccines are scheduled. 

Agenda items are subject to change as 

priorities dictate. For more information 

on the meeting agenda, visit https://

www.cdc.gov/vaccines/acip/meetings/ 

index.html. 

Meeting Information: The meeting 

will be webcast live via the World Wide 

Web. For more information on ACIP, 

please visit the ACIP website: https://

www.cdc.gov/vaccines/acip/index.html. 

Public Participation 

Interested persons or organizations 

are invited to participate by submitting 

written views, recommendations, and 

data. Please note that comments 

received, including attachments and 

other supporting materials, are part of 

the public record and are subject to 

public disclosure. Comments will be 

posted on https://www.regulations.gov. 

Therefore, do not include any 

information in your comment or 

supporting materials that you consider 

confidential or inappropriate for public 

disclosure. If you include your name, 

contact information, or other 

information that identifies you in the 

body of your comments, that 

information will be on public display. 

CDC will review all submissions and 

may choose to redact, or withhold, 

submissions containing private or 

proprietary information such as Social 

Security numbers, medical information, 

inappropriate language, or duplicate/ 

near-duplicate examples of a mass-mail 

campaign. CDC will carefully consider 

all comments submitted into the docket. 

Written Public Comment: The docket 

will be opened to receive written 

comments on August 25, 2023. Written 

comments must be received by 

September 8, 2023. 

Oral Public Comment: This meeting 

will include time for members of the 

public to make an oral comment. 

Priority will be given to individuals 

who submit a request to make an oral 

public comment before the meeting 

according to the procedures below. 

Procedure for Oral Public Comment: 

All persons interested in making an oral 

public comment at the September 12, 

2023, ACIP meeting must submit a 

request at https://www.cdc.gov/ 

vaccines/acip/meetings/index.html no 

later than 11:59 p.m., EDT, September 8, 

2023, according to the instructions 

provided. 

If the number of persons requesting to 

speak is greater than can be reasonably 

accommodated during the scheduled 

time, CDC will conduct a lottery to 

determine the speakers for the 

scheduled public comment session. 

CDC staff will notify individuals 

regarding their request to speak by email 

on September 11, 2023. To 

accommodate the significant interest in 

participation in the oral public 

comment session of ACIP meetings, 

each speaker will be limited to three 

minutes, and each speaker may only 

speak once per meeting. 

The Director, Office of Strategic 

Business Initiatives, Office of the Chief 

Operating Officer, Centers for Disease 

Control and Prevention, has been 

delegated the authority to sign Federal 

Register notices pertaining to 

announcements of meetings and other 

committee management activities, for 

both the Centers for Disease Control and 

Prevention and the Agency for Toxic 

Substances and Disease Registry. 

Kalwant Smagh, 

Director, Office of Strategic Business 

Initiatives, Office of the Chief Operating 

Officer, Centers for Disease Control and 

Prevention. 

[FR Doc. 2023–18288 Filed 8–24–23; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

[60–Day–23–23HS; Docket No. CDC–2023– 

0074] 

Proposed Data Collection Submitted 

for Public Comment and 

Recommendations 

AGENCY: Centers for Disease Control and 

Prevention (CDC), Department of Health 

and Human Services (HHS). 

ACTION: Notice with comment period. 

SUMMARY: The Centers for Disease 

Control and Prevention (CDC), as part of 

its continuing effort to reduce public 

burden and maximize the utility of 

government information, invites the 

general public and other Federal 

agencies the opportunity to comment on 

a proposed and/or continuing 

information collection, as required by 

the Paperwork Reduction Act of 1995. 

This notice invites comment on a 

proposed information collection project 

titled Program Evaluation for PS22– 

2208 Component 2. This information 

collection request is designed to 

monitor and evaluate the PS22–2208 

Component 2 funding opportunity’s 

overall goal of supporting syringe 

services program (SSP) subrecipients in 

meeting the needs of people who use 

drugs (PWUD) and reducing infectious 

disease and other harms related to drug 

use during the 5-year PS22–2208 

Cooperative Agreement. 

DATES: CDC must receive written 

comments on or before October 24, 

2023. 

ADDRESSES: You may submit comments, 

identified by Docket No. CDC–2023– 

0074 by either of the following methods: 


ddrumheller on DSK120RN23PROD with NOTICES1